Did The Market Overreact To Inovio Pharmaceuticals' Clinical Hold?

The Food and Drug Administration places a clinical hold! Inovio Pharmaceuticals' (NASDAQ: INO) shares nosedive! The end is near!While the first two overly punctuated statements are true, the last one isn't. (At least, I don't think it is.) Yes, the FDA recently put a clinical hold on a late-stage study planned by Inovio.

Topics:  food   drug administration    inovio pharmaceuticals nasdaq   ino     yes   fda   inovio   i    inovio    market   overreact   
BING NEWS:
  • Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation
    Inovio Pharmaceuticals faces financial and valuation concerns, with a high valuation multiple and a low cash runway. Find out why I rate INO stock a 'hold'.
    04/24/2024 - 1:37 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News